๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-07-06

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions. (NCT07225751)

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions

๐ŸŸข Recruiting Observational / Diagnostic โš™๏ธ Medical Device Protocol Sponsor: Kuros Biosurgery AG

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use according to the latest Instructions For Use, standalone in the foot and ankle.

Who can join: Review the eligibility criteria below.

Location: Steadman Philippon Research Institute โ€” Vail, Colorado

Age range: 18 Years to 75 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (6 Sites)

  • Steadman Philippon Research Institute โ€” Vail, Colorado
  • Hughston Foundation Inc โ€” Columbus, Georgia
  • OrthoCarolina Research Institute, Inc โ€” Charlotte, North Carolina
  • Reconstructive Orthopaedic Associates II dba Rothman Orthopaedic Institute โ€” Philadelphia, Pennsylvania
  • Integrity Orthopedics and Sports Medicine โ€” Chattanooga, Tennessee
  • Centers for Advanced Orthopaedics โ€” Falls Church, Virginia

๐Ÿ“ž Contact the Study Coordinator

Phone: (970) 215-6793

Email: cesar.silva@kurosbio.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—